Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heilongjiang Quangle Pharmaceutical is a Chinese pharmaceutical company based in Harbin, specializing in the development, production, and sale of chemical drugs and traditional Chinese medicines. The company operates large-scale manufacturing facilities that produce a variety of dosage forms, including tablets, capsules, and granules. Its product portfolio is heavily focused on anti-infectives, particularly antibiotics such as cephalosporins and quinolones, as well as treatments for cardiovascular and gastrointestinal conditions. Quangle Pharmaceutical maintains Good Manufacturing Practice (GMP) certification for its production lines, ensuring compliance with national quality standards. The company serves the domestic Chinese market through an established distribution network, providing essential medicines to hospitals and pharmacies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Heilongjiang Quangle Pharmaceutical.